외과용 봉합사 시장 보고서 : 유형, 소재, 용도, 최종사용자, 지역별(2026-2034년)

The global surgical sutures market size reached USD 5.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.86% during 2026-2034. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.

SURGICAL SUTURES MARKET ANALYSIS:

• Major Market Drivers: The primary factors supporting the global market, includes the escalating prevalence of road accidents, which has considerably surged the numbers for trauma surgeries, which is further improving the surgical sutures market revenue. Furthermore, the surging demand for robotic sutures due to their precision and the escalating awareness among the healthcare providers regarding the advantages of advanced sutures are further shaping the surgical suture market outlook. Apart from this, the increase in public healthcare investments, burgeoning focus on surgical training and education, and availability of affordable reimbursement scenarios are providing a thrust to the market growth.
• Key Market Trends: Key market players are offering customization options to cater to umpteen surgical requirements, which represents one of the key market trends boosting the surgical suture market trends. In line with this, the shifting preference of healthcare providers toward eco-friendly and biodegradable sutures, due to their lower infection risks and consistent performance, is aligning with positive surgical sutures market statistics. Furthermore, the burgeoning investments in research and development (R&D) activities to develop suture materials that facilitate minimum scarring is accelerating the surgical suture market growth.
• Geographical Trends: North America leads the market primarily due to the regions growing emphasis on innovation and surgical excellence. In line with this, the burgeoning healthcare expenditure, rapid development of advanced healthcare infrastructure, and presence of key market players are bolstering the regional market growth. Apart from this, Asia Pacific is rapidly expanding market for surgical sutures, due to the regions surging awareness of advanced materials and escalating medical tourism.
• Competitive Landscape: Some of the major market players in the surgical sutures industry include Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, and CONMED Corporation, among others. In September 2022, B. Braun Medical Inc. (B. Braun) acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. The company's acquisition builds on the company's history of product and program innovation to improve the patient outcomes and experience with peripheral intravenous (IV) therapy. The competitive landscape of the surgical sutures market is highly dynamic, featuring a mix of global players and regional contenders. This competition fosters innovation, leading to the development of advanced suture materials that cater to various surgical needs, thereby enhancing the surgical suture market outlook.
• Challenges and Opportunities: Growing competition from substitute wound closure alternatives, such as surgical staples and adhesives, could disrupt revenue generation in the surgical sutures market, which is one of the major challenges for the market. There's also the ongoing issue of surgical site infections associated with sutures, necessitating rigorous research to develop infection-resistant materials. However, these challenges pave the way for numerous opportunities, such as the potential for innovations in antimicrobial sutures or biodegradable options that can revolutionize wound management, boosting the surgical sutures market growth.

SURGICAL SUTURES MARKET TRENDS:

Escalating chronic diseases prevalence

Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.

Development of advanced suture materials

Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.

Burgeoning prevalence of cosmetic surgeries

The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.

SURGICAL SUTURES MARKET SEGMENTATION:

Breakup by Type:

• Absorbable Sutures
• Non-Absorbable Sutures

Absorbable sutures accounts for the majority of the market share

The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.

Breakup by Material:

• Monofilament
• Multifilament

Multifilament holds the largest share of the industry

The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.

Breakup by Application:

• Cardiovascular Surgeries
• General Surgeries
• Gynecological Surgeries
• Orthopedic Surgeries
• Ophthalmic Surgeries
• Others

Cardiovascular Surgeries represents the leading market segment

The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Hospitals and clinics exhibits a clear dominance in the market

The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest surgical sutures market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.

The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.

COMPETITIVE LANDSCAPE:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the surgical sutures industry include Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, DemeTECH Corporation, Integra LifeSciences, Johnson & Johnson, Medtronic plc, Mellon Medical B.V., Smith & Nephew plc, Stryker Corporation, Teleflex Incorporated and Zimmer Biomet. ()
• The key players in the surgical suture market are actively engaged in innovative strategies to develop advanced products and technologies that meet the growing clinical requirements and improve patient outcomes. For instance, in 2022, Johnson & Johnson launched their latest innovation in surgical sutures, the Ethicon STRATAFIX(TM) Spiral Knotless Tissue Control Devic. In addition, the report indicates that the drive towards the development of antimicrobial coatings integrated is boosted by the surging concern about the increased risk of surgical site affections, especially in high-risk settings such as hospitals and surgical centers. Other strategies include the development of innovative delivery systems and materials that enhance the ease of use, efficiency, and safety of suturing procedures. Key players may also establish partnerships with providers, research organizations, and regulatory authorities to drive innovation trends, enhance presence in the market, and ensure adherence to industry requirements and standards.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the surgical sutures market?

2. What is the expected growth rate of the global surgical sutures market during 2026-2034?

3. What has been the impact of COVID-19 on the global surgical sutures market?

4. What are the key factors driving the global surgical sutures market?

5. What is the breakup of the global surgical sutures market based on the type?

6. What is the breakup of the global surgical sutures market based on the material?

7. What is the breakup of the global surgical sutures market based on the application?

8. What is the breakup of the global surgical sutures market based on the end user?

9. What are the key regions in the global surgical sutures market?

10. Who are the key players/companies in the global surgical sutures market?

11. What is the new technology for sutures?

12. What is the most commonly used suture?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Surgical Sutures Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Absorbable Sutures
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Non-Absorbable Sutures
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Material

• 7.1 Monofilament
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Multifilament
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Cardiovascular Surgeries
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 General Surgeries
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Gynecological Surgeries
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Orthopedic Surgeries
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Ophthalmic Surgeries
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Advanced Medical Solutions Group plc
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 B. Braun Melsungen AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 SWOT Analysis
  • 15.3.3 Boston Scientific Corporation
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 CONMED Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 DemeTECH Corporation
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Integra LifeSciences
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Johnson & Johnson
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Medtronic plc
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Mellon Medical B.V.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Smith & Nephew plc
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Stryker Corporation
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
    • 15.3.11.3 Financials
    • 15.3.11.4 SWOT Analysis
  • 15.3.12 Teleflex Incorporated
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis
  • 15.3.13 Zimmer Biomet
    • 15.3.13.1 Company Overview
    • 15.3.13.2 Product Portfolio
    • 15.3.13.3 Financials
    • 15.3.13.4 SWOT Analysis